Early analysis to the effect on the pandemic on EU drug markets indicated that the effects of COVID-19 restrictions seemed to be more visible with the retail degree than in the wholesale level. Whilst massive quantities of copyright ended up available in Europe, the logistics of transporting more compact batches, which include retail portions, had